Results 131 to 140 of about 377,839 (219)

Measles, mumps, rubella (MMR) vaccine

Ceylon Medical Journal, 2011
openaire   +3 more sources

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. [PDF]

Vaccine
Quach HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +5 more
europepmc   +1 more source

Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]

Cureus
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know

MMR vaccine can prevent measles, mumps, and rubella.mmr.pdf1. Why get vaccinated? -- 2. MMR vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction-- 5. What if there is a serious problem? \u2013 6. The National Vaccine Injury

core  

Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]

Med Devices (Auckl)
Ratta BS, Naik A, Mutha S.
europepmc   +1 more source

Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine. [PDF]

Vaccine, 2020
Crooke SN, Ovsyannikova IG, Kennedy RB, Warner ND, Poland GA.   +4 more
europepmc   +1 more source

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]

Health Sci Rep
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc   +1 more source

Understanding MMR vaccine safety [PDF]

Last updated February 2013CDC recommends two doses of the measles, mumps, and rubella vaccine (MMR) for children because it protects them against dangerous, even deadly, diseases.CS233434Nvacsafe-mmr-color-office ...

core  

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source

Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial. [PDF]

Trials, 2020
Vittrup DM, Laursen ACL, Malon M, Soerensen JK, Hjort J, Buus S, Svensson J, Stensballe LG.   +7 more
europepmc   +1 more source